Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $204B | +$3.45B | 219 | 4.04% | Increased |
|
| 2 |
BlackRock
New York
| $176B | +$717M | 216 | 4.09% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $91.9B | +$356M | 193 | 4.11% | Increased |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $43.3B | +$1.54B | 229 | 4.01% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $40.3B | +$1.44B | 161 | 2.7% | Increased |
|
| 6 |
Morgan Stanley
New York
| $39.7B | -$444M | 229 | 3.19% | Reduced |
|
| 7 |
T. Rowe Price Associates
Baltimore,
Maryland
| $36B | -$596M | 125 | 4.41% | Reduced |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $34.6B | -$2.3B | 63 | 6.13% | Reduced |
|
| 9 |
JP Morgan Chase
New York
| $31.6B | +$2.14B | 201 | 2.67% | Increased |
|
| 10 |
Capital Research Global Investors
Los Angeles,
California
| $28.1B | -$896M | 20 | 6.37% | Reduced |
|
| 11 |
Bank of New York Mellon
New York
| $26.2B | +$215M | 149 | 5.04% | Increased |
|
| 12 |
Norges Bank
Oslo,
Norway
| $25.1B | +$1.53B | 84 | 3.97% | Increased |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $21.9B | +$1.73B | 194 | 1.99% | Increased |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $21.6B | -$942M | 194 | 3.73% | Reduced |
|
| 15 |
Massachusetts Financial Services
Boston,
Massachusetts
| $21B | -$556M | 40 | 6.28% | Reduced |
|
| 16 |
Invesco
Atlanta,
Georgia
| $19.6B | +$843M | 122 | 4.21% | Increased |
|
| 17 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $17.2B | +$303M | 30 | 10.53% | Increased |
|
| 18 |
Franklin Resources
San Mateo,
California
| $17.2B | +$2.69B | 105 | 5.45% | Increased |
|
| 19 |
Capital International Investors
Los Angeles,
California
| $15.1B | -$2.07B | 8 | 3.05% | Reduced |
|
| 20 |
AllianceBernstein
Nashville,
Tennessee
| $14B | -$1.9B | 124 | 4.95% | Reduced |
|
| 21 |
Legal & General Group
London,
United Kingdom
| $13.7B | -$146M | 134 | 3.95% | Reduced |
|
| 22 |
Charles Schwab
San Francisco,
California
| $13.6B | +$269M | 149 | 3.13% | Increased |
|
| 23 |
Nuveen
Charlotte,
North Carolina
| $13B | +$139M | 131 | 3.86% | Increased |
|
| 24 |
Goldman Sachs
New York
| $12.6B | -$1.33B | 149 | 2.24% | Reduced |
|
| 25 |
Ameriprise
Minneapolis,
Minnesota
| $12.5B | +$337M | 119 | 3.45% | Increased |
|